BofA Sees Big Potential in Vera Therapeutics' Autoimmune Drug
Bank of America starts coverage on Vera Therapeutics with Buy rating and $48 target, citing Atacicept's potential in multibillion-dollar autoimmune disease market.
NOTRELOAD AI
Analysts Bullish on Digital Asset Treasury Companies: SharpLink Gaming Leads the Pack
B. Riley and Citizens JMP initiate coverage on digital asset treasury stocks with Buy ratings. SharpLink Gaming emerges as top pick with significant upside potential.
JPMorgan Upgrades Las Vegas Sands Stock on Singapore Potential
JPMorgan raises Las Vegas Sands to Overweight with $60 target, citing undervalued Singapore operations and stable Macau outlook after recent stock pullback.
Citi Boosts Micron Price Target to $240 on Strong DRAM Outlook
Citi boosts Micron stock target to $240, citing sustainable DRAM pricing and AI demand. Analyst predicts 60% margins and $23+ EPS, nearly double previous peak.
TSMC Doubles Down on AI: Chipmaker Raises 2025 Revenue Forecast Amid Global Semiconductor Boom
TSMC boosts 2025 revenue growth forecast to mid-30% for second time this year, citing stronger-than-expected AI chip demand despite geopolitical challenges.
Nio Stock Plunges Following Lawsuit by Singapore's GIC Over Revenue Practices
EV maker Nio was sued by Singapore's GIC (a fund) over claims Nio inflated revenue via battery sales. Nio stock fell sharply.